Glenmark Pharmaceuticals has received final approval from the United States health regulator for its generic Fluticasone propionate lotion used in treating skin pain and itching caused by eczema. Fluticasone propionate 0.05 per cent lotion by Glenmark is generic version of Nycomed’s Cultivate lotion. Nycomed had filed a patent infringement suit in the US District Court, of New York in December 2008, challenging Glenmark’s ANDA for Fluticasone propionate lotion.
According to IMS health sales data ending December 2010 Cultivate lotion achieved annual sales of nearly $48 million in the American market..
